galactosamine has been researched along with hesperetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Buist-Homan, M; Cai, B; Cheng, H; Faber, KN; Jiang, J; Li, L; Luo, X; Moshage, H; Shen, D; Shi, G; Yang, P; Zhou, Q | 1 |
| Bai, YF; Fan, XY; Sheng, H; Wang, SW; Wang, W; Weng, YY; Xu, ZC; Zhang, F; Zheng, F; Zhu, XT | 1 |
2 other study(ies) available for galactosamine and hesperetin
| Article | Year |
|---|---|
The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro.
Topics: Animals; Biological Products; Concanavalin A; Dose-Response Relationship, Drug; Galactosamine; Hesperidin; In Vitro Techniques; Lipopolysaccharides; Liver Failure, Acute; Male; Protective Agents; Rats; Rats, Wistar | 2017 |
Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway.
Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Enzyme Activation; Galactosamine; HEK293 Cells; Hesperidin; Humans; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Protein Processing, Post-Translational; RAW 264.7 Cells; Signal Transduction; Sirtuin 1; Transcription Factor RelA | 2020 |